🧬 RNAwiki
HomeCompareLL-37 vs Thymosin Alpha-1 (Zadaxin)

LL-37 vs Thymosin Alpha-1 (Zadaxin)

Both are used for immunity. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.

LL-37Thymosin Alpha-1 (Zadaxin)
Human evidence★★☆☆☆★★★☆☆
Legal statusNot ApprovedPrescription, Not Approved
How it worksHuman cathelicidin (CAMP gene) antimicrobial peptide; disrupts microbial membranes and modulates immunity/wound healing.Immunomodulator activating Toll-like receptors (TLR9/2) and T-cell maturation; approved in ~35 countries for hepatitis B/C and as a vaccine adjuvant.
In plain EnglishA natural antibiotic your own body makes; explored for infections and healing. Very early for supplemental use.Tunes up the immune system's T-cells — approved in many countries (not the US) for chronic infections and used to bolster immunity.
Bottom lineInteresting antimicrobial biology; minimal human supplement data.Real immunotherapy abroad; investigational in the US.
AvailabilityNot widely approvedPrescription only

Which is better for immunity?

Thymosin Alpha-1 (Zadaxin) has the stronger human-evidence rating (★★★☆☆ vs ★★☆☆☆), but the right choice still depends on your goal, tolerance and budget.

Full breakdowns: LL-37 · Thymosin Alpha-1 (Zadaxin).

Common questions

Is LL-37 or Thymosin Alpha-1 (Zadaxin) better for immunity?

Thymosin Alpha-1 (Zadaxin) has the stronger human-evidence rating (★★★☆☆ vs ★★☆☆☆), but the right choice still depends on your goal, tolerance and budget.

What's the difference between LL-37 and Thymosin Alpha-1 (Zadaxin)?

LL-37: Interesting antimicrobial biology; minimal human supplement data. — Thymosin Alpha-1 (Zadaxin): Real immunotherapy abroad; investigational in the US.